Scribe Therapeutics, Inc. (SCTX)
Scribe Therapeutics, Inc. (SCTX) is a Healthcare stock tracked by StreetAlpha. It last closed at $12.07 on Nov 20, down 8.70% on the day. The next earnings report for SCTX is expected around Thu, Feb 11, 2027, after the close. For the quarter ended Sep 2026, SCTX reported EPS of -$0.68. Over the last 12 months SCTX insiders bought $71.3M of stock on the open market and sold $0, according to SEC Form 4 filings.
Earnings
Full earnings history →Analyst Ratings & Price Targets
Analyst Ratings →StreetAlpha's curated list of analyst calls collected from around the web. It may be incomplete or inaccurate, is not a consensus and is not advice.
- Every upgrade, downgrade and initiation as it happens
- Every price target change, raised or cut
- Consensus rating with the average, high and low targets
- Each firm's full rating history on SCTX
Technical AnalysisPrices may be delayed
The stock is 31% below its 20 day and 62% below its 50 day average. Momentum is weak (RSI 31), near oversold. The nearest support is the 52 week low at $12.00, and the nearest resistance the Pivot at $12.49.
| RSI (14) | 30.56 | Weak, oversold below 30 | Neutral |
| MACD | -1.52 | Below its signal line | Bearish |
| Stochastic | 4.5 | Near the bottom of its range | Oversold |
| ADX (14) | 20.8 | Weak trend | |
| Williams %R | -98.9 | Oversold below −80, overbought above −20 | Oversold |
| CCI (20) | -266.6 | Oversold below −100, overbought above 100 | Oversold |
| Rate of change | −23.1% | Change over 10 sessions | Bearish |
| ATR (14) | $1.95 | Typical daily range, 16.1% of price |
What happened before
See how SCTX did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
Whale Options FlowPrices may be delayed
90DNo whale options trades in SCTX in the last 90 days.
SCTX Institutional Ownership
Full report →- ▲63 buying vs 0 selling
- ▲Held by funds +85.5 pts
- ●Funds holding +63
- ▲Superinvestors: 2 added, 0 cut
- ●Put/call not meaningful
| Q3 2026 | This quarter | Last quarter | Change |
|---|---|---|---|
| Funds holding | 63 | – | – |
| In funds' top 10 | 2 | – | – |
| Held by funds | 85.5% | – | – |
| New / increased | 63 / 0 | – | – |
| Reduced / sold out | 0 / 0 | – | – |
| Put/call ratio | – | – | – |
From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.
SCTX Insider Trading
All filings →| Trade date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 28 | Behzad AghazadehDirector | Buy | 2,391,238 | $15.16 | $36.3M |
| Jul 27 | Orbimed Advisors LLCDirector | Buy | 1,000,000 | $15.00 | $15.0M |
| Jul 27 | Carl L GordonDirector | Buy | 1,000,000 | $15.00 | $15.0M |
| Jul 27 | AH Bio Fund II, L.P.10% owner | Buy | 333,333 | $15.00 | $5.0M |
| Jul 23 | Svetlana LucasChief Business Officer | Buy | 3,000 | $15.00 | $45K |
| Jul 23 | David ParrotCFO | Buy | 2,666 | $15.00 | $40K |
From SEC Form 4 filings by SCTX's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.
AI Auto Pilots
Paper tradingStreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether SCTX is in one of them and how their past SCTX trades turned out.
SCTX News Tone and PricePrices may be delayed
Macro & Market News
All StreetAlpha news →StreetAlpha hasn't covered SCTX in an article yet. Here's the latest on the wider market.

